Glabridin synergy with norfloxacin induces ROS in multidrug resistant Staphylococcus aureus

J Gen Appl Microbiol. 2021 Dec 31;67(6):269-272. doi: 10.2323/jgam.2021.06.002. Epub 2021 Oct 23.

Abstract

Glabridin (Glb), a polyphenolic flavonoid inhibits the growth of MDRSA (Multidrug resistant S. aureus) 4627 by inducing ROS. Glb in combination with Norfloxacin (Nor) synergistically induced oxidative stress. Increased ROS/RNS levels, in particular, affected macromolecules' (DNA, lipid, protein) integrity and distorted cell morphology. We found correlation between drug-effects and up-/down-regulation of oxidative stress-related as well as MDR genes. These findings could considerably potentiate the dosing routine of Nor in combination with Glb, which holds a promising prospective as a antibacterial agent against S. aureus.

Keywords: S. aureus; drug resistance; glabridin; norfloxacin; reactive oxygen species.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Isoflavones
  • Methicillin-Resistant Staphylococcus aureus*
  • Microbial Sensitivity Tests
  • Norfloxacin* / pharmacology
  • Phenols
  • Prospective Studies
  • Reactive Oxygen Species
  • Staphylococcus aureus

Substances

  • Anti-Bacterial Agents
  • Isoflavones
  • Phenols
  • Reactive Oxygen Species
  • glabridin
  • Norfloxacin